Last reviewed · How we verify
Intraumbilical vein injection oxytocin — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Intraumbilical vein injection oxytocin (Intraumbilical vein injection oxytocin) — Eslam Mohammed Abbas.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intraumbilical vein injection oxytocin TARGET | Intraumbilical vein injection oxytocin | Eslam Mohammed Abbas | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intraumbilical vein injection oxytocin CI watch — RSS
- Intraumbilical vein injection oxytocin CI watch — Atom
- Intraumbilical vein injection oxytocin CI watch — JSON
- Intraumbilical vein injection oxytocin alone — RSS
Cite this brief
Drug Landscape (2026). Intraumbilical vein injection oxytocin — Competitive Intelligence Brief. https://druglandscape.com/ci/intraumbilical-vein-injection-oxytocin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab